Journal of Cardiovascular and Thoracic Research,
Journal Year:
2024,
Volume and Issue:
16(4), P. 275 - 280
Published: Dec. 23, 2024
Introduction:
Limited
real-world
data
exist
regarding
cardiovascular
outcomes
in
post-COVID-19
individuals
following
discharge,
particularly
within
the
Asian
Indian
population.
This
study
aims
to
explore
association
between
prior
COVID-19
history
and
in-hospital
acute
myocardial
infarction
patients.
Methods:
Hospital
database
was
searched
for
patients
who
were
diagnosed
with
Acute
(AMI)
grouped
according
absence
(Group-A)
or
presence
(Group-B)
of
severe
hospitalization
at
least
3
months
index
event
AMI.
Study
primary
endpoint
defined
as
major
adverse
events
(MACE)
comprising
Re-AMI,
stroke,
death
(3P)
decompensated
heart
failure
(4P),
which
analyzed
these
2
groups.
Results:
Of
10,581
consecutive
AMI,
5.33%
(n=564/10,581)
had
SARS-CoV-2
beyond
Past
Covid-19
presenting
AMI
more
likely
be
younger
(59.12+11.23
years
vs.
52.01+10.05
years)
than
40
age.
Patients
Group
B
demonstrated
a
notably
higher
prevalence
diabetes,
hypertension,
Killip
class,
lower
LVEF
compared
A.
In-hospital
cardiac
arrest,
all-cause
significantly
Higher
unadjusted
odds
ratio
hospital
OR=5.78
(2.56-10.23),
3-P
MACE
OR=2.33
(1.23-8.65)
4-P
OR=2.58
(1.36-5.43)
found
COVID-19.
After
adjusting
comorbidities,
non-significant.
Conclusion:
Conventional
risk
factors
comorbidities
increased
both
3P
4P
during
Frontiers in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 19, 2024
The
COVID-19
pandemic
has
challenged
global
health
systems
since
December
2019,
with
the
novel
virus
SARS-CoV-2
causing
multi-systemic
disease,
including
heart
complications.
While
acute
cardiac
effects
are
well-known,
long-term
implications
understudied.
This
review
hopes
to
fill
a
gap
in
literature
and
provide
valuable
insights
into
consequences
of
virus,
which
can
inform
future
public
policies
clinical
practices.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(23), P. 7265 - 7265
Published: Nov. 29, 2024
Background:
The
long-term
risk
of
cardiovascular
and
thrombotic
events
following
severe
COVID-19
remains
largely
unknown.
This
study
aimed
to
assess
the
atherosclerotic
disease
(ASCVD)
within
one
year
after
hospital
discharge
in
patients
who
received
intensive
care
for
COVID-19.
Methods:
A
register-based
nationwide
case-control
on
a
cohort
with
(cases)
requiring
mechanical
ventilation
discharged
alive
without
experiencing
or
during
their
stay.
Each
case
was
matched
(age,
sex,
district
residence)
up
10
population-based
controls.
primary
outcome
ASCVD
occurring
discharge,
defined
as
composite
endpoint,
including
myocardial
infarction
(MI),
unstable
angina
pectoris
ischemic
stroke.
Secondary
endpoints
were
MI,
stroke,
all-cause
mortality,
venous
thromboembolic
events.
Hazard
ratio
(HR)
(95%
CI)
used
adjustments
age,
socioeconomic
factors,
co-morbidities.
Results:
In
total,
31,375
individuals
(70%
men,
median
age
62
years)
included,
which
2854
had
26,885
control
subjects.
adjusted
HR
first
compared
subjects
3.1
CI
1.7–5.4).
Adjusted
HRs
secondary
outcomes
2.0
0.8–5.3),
stroke
1.9
0.7–5.3),
pulmonary
embolism
49.4
28.0–87.1),
deep
thrombosis
(DVT)
16.0
7.8–32.6).
Conclusions:
Severe
associated
substantial
increase
1-year
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 28, 2024
Abstract
This
study
investigated
the
incidence
of
new-onset
cardiovascular
disorders
up
to
3.5
years
post
SARS-CoV-2
infection
for
56,400
individuals
with
COVID-19
and
1,093,904
contemporary
controls
without
in
Montefiore
Health
System
(03/11/2020
07/01/2023).
Outcomes
were
new
major
adverse
event
(MACE),
arrhythmias,
inflammatory
heart
disease,
thrombosis,
cerebrovascular
disorders,
ischemic
disease
other
cardiac
between
30
days
(up
to)
index
date.
Results
also
compared
a
pre-pandemic
cohort
over
similar
observation
duration
(
N
=
64,541).
Cumulative
hazard
ratios
adjusted
competitive
risks
analyzed.
Compared
controls,
hospitalized
patients
had
significantly
higher
risk
developing
MACE
(aHR
2.29,
95%
confidence
interval
[2.27,
2.31],
p
<
0.001),
arrhythmias
2.54[2.50,
2.58],
5.34[4.79,
5.96],
2.05[2.00,
2.11],
2.31[2.26,
2.35],
thrombosis
4.25[4.15,
4.36],
1.89[1.86,
1.92],
0.001).
Non-hospitalized
slightly
1.04[1.03,
1.06],
1.10[1.08,
1.12],
2.29
[2.03,
2.59],
1.11[1.07,
1.15],
1.13],
Race
ethnicity
mostly
not
associated
increased
>
0.05).
aHRs
as
reference
those
reference.
We
concluded
that
incident
patients,
especially
COVID-19,
than
controls.
Identifying
factors
may
draw
clinical
attention
need
careful
follow-up
at-risk
individuals.
Journal of Cardiovascular and Thoracic Research,
Journal Year:
2024,
Volume and Issue:
16(4), P. 275 - 280
Published: Dec. 23, 2024
Introduction:
Limited
real-world
data
exist
regarding
cardiovascular
outcomes
in
post-COVID-19
individuals
following
discharge,
particularly
within
the
Asian
Indian
population.
This
study
aims
to
explore
association
between
prior
COVID-19
history
and
in-hospital
acute
myocardial
infarction
patients.
Methods:
Hospital
database
was
searched
for
patients
who
were
diagnosed
with
Acute
(AMI)
grouped
according
absence
(Group-A)
or
presence
(Group-B)
of
severe
hospitalization
at
least
3
months
index
event
AMI.
Study
primary
endpoint
defined
as
major
adverse
events
(MACE)
comprising
Re-AMI,
stroke,
death
(3P)
decompensated
heart
failure
(4P),
which
analyzed
these
2
groups.
Results:
Of
10,581
consecutive
AMI,
5.33%
(n=564/10,581)
had
SARS-CoV-2
beyond
Past
Covid-19
presenting
AMI
more
likely
be
younger
(59.12+11.23
years
vs.
52.01+10.05
years)
than
40
age.
Patients
Group
B
demonstrated
a
notably
higher
prevalence
diabetes,
hypertension,
Killip
class,
lower
LVEF
compared
A.
In-hospital
cardiac
arrest,
all-cause
significantly
Higher
unadjusted
odds
ratio
hospital
OR=5.78
(2.56-10.23),
3-P
MACE
OR=2.33
(1.23-8.65)
4-P
OR=2.58
(1.36-5.43)
found
COVID-19.
After
adjusting
comorbidities,
non-significant.
Conclusion:
Conventional
risk
factors
comorbidities
increased
both
3P
4P
during
